Anna Protopapas's Net Worth
$6.83 Million
Who is Anna Protopapas?
Anna Protopapas has an estimated net worth of $6.83 Million. This is based on reported shares across multiple companies, which include Dicerna Pharmaceuticals Inc, Nuvalent, Inc., Mersana Therapeutics, Inc., Bioverativ Inc., ARIAD PHARMACEUTICALS INC, and MILLENNIUM PHARMACEUTICALS INC.
SEC CIK
Anna Protopapas's CIK is 0001347582
Past Insider Trading and Trends
2007 was Anna Protopapas's most active year for acquiring shares with 17 total transactions. Anna Protopapas's most active month to acquire stocks was the month of December. 2007 was Anna Protopapas's most active year for disposing of shares, totalling 29 transactions. Anna Protopapas's most active month to dispose stocks was the month of April. 2017 saw Anna Protopapas paying a total of $1,869,602.97 for 77,487 shares, this is the most they've acquired in one year. In 2008 Anna Protopapas cashed out on 443,879 shares for a total of $4,583,256.28, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Dicerna Pharmaceuticals Inc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 3.33K |
—
|
—
| 3.33K |
Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Nuvalent, Inc. (NUVL) Snapshot price: $86.25
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.5K |
—
|
—
| 2.5K |
Jun 12
| |||
Form 4
|
—
|
0
|
$42.52 | -$331,550.00 |
0
|
Dec 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Mersana Therapeutics, Inc. (MRSN) Snapshot price: $1.35
President & CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
| +85.15% | 57.56K |
$2.71 | -$79,671.29 | 125.15K |
Scheduled
|
Jan 13 - Jan 16
| ||
Form 4
| +32.66% | 16.64K |
—
|
—
| 67.59K |
Sep 11
| |||
Form 4
| +15.31% | 38.36K |
$5.74 | -$99,566.04 | 288.98K |
May 20 - Jan 17
| |||
Form 4
| +13.72% | 38.96K |
—
|
—
| 322.88K |
Jan 14
| |||
Form 4
| +25.81% | 58.06K |
$12.24 | -$513,186.23 | 282.98K |
Jul 15 - Jul 19
| |||
Form 4
| +5.89% | 12.51K |
$21.09 | -$109,625.82 | 224.92K |
Jan 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 2
| |||
Form 4
| +8.66% | 10.42K |
$1.53 | $15,938.01 | 130.72K |
Dec 20
| |||
Form 4
| +60.07% | 72.26K |
—
|
—
| 192.56K |
Jul 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Bioverativ Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -1.06K |
—
|
—
|
0
|
Mar 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 31
| |||
Form 4
|
∞
| 1.06K |
$56.83 | $60,012.48 | 1.06K |
Apr 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
ARIAD PHARMACEUTICALS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -41.91K |
—
|
—
|
0
|
Feb 16
| |||
Form 4
| +75.34% | 18.01K |
—
|
—
| 41.91K |
Jan 31
| |||
Form 4
|
∞
| 23.9K |
—
|
—
| 23.9K |
Feb 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |